Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Latest news  /  
  • Independent batch release testing of COVID-19 (coronavirus) vaccines

Independent batch release testing of COVID-19 (coronavirus) vaccines

As is the case for current, licensed vaccines, the quality of each batch of any potential COVID-19 vaccine will be evaluated by an independent laboratory. The independent laboratory will also carry out a thorough review of the manufacturer batch documentation that describes the production process and quality control testing performed by the company.

In the UK, this independent testing is performed by the National Institute for Biological Standards and Control (NIBSC). Before any batch can be released for deployment, the NIBSC will issue a certificate confirming that the independent testing has been performed and that the batch is compliant with the relevant specifications for the product.

Further information on batch release
 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap